Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Amira Nature Foods (ANFI) Stock Price

Share on StockTwits

News stories about Amira Nature Foods (NYSE:ANFI) have been trending somewhat positive recently, according to Accern. The research group ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Amira Nature Foods earned a media sentiment score of 0.06 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 48.3296415249262 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Amira Nature Foods traded down $0.07, reaching $1.77, during mid-day trading on Friday, MarketBeat.com reports. The stock had a trading volume of 282,916 shares, compared to its average volume of 158,285. Amira Nature Foods has a 12 month low of $1.62 and a 12 month high of $6.30.

Separately, S&P Equity Research lifted their price objective on shares of Amira Nature Foods from $2.65 to $3.25 in a research note on Thursday, May 10th.

About Amira Nature Foods

Amira Nature Foods Ltd. engages in processing, sourcing, and selling packaged Indian specialty rice. The company provides various types of basmati rice, other specialty rice and other food products, ready-to-eat snacks, edible oils, and organic products for retailers under the Amira brand; and non-basmati rice.

Featured Story: How Short Selling Works

Insider Buying and Selling by Quarter for Amira Nature Foods (NYSE:ANFI)

Receive News & Ratings for Amira Nature Foods Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amira Nature Foods and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Auctus  Reaches Market Cap of $1.02 Million
Auctus Reaches Market Cap of $1.02 Million
Statoil  versus Repsol  Financial Review
Statoil versus Repsol Financial Review
BrahmaOS Price Reaches $0.0110 on Exchanges
BrahmaOS Price Reaches $0.0110 on Exchanges
Investors Sell Altaba  on Strength on Analyst Downgrade
Investors Sell Altaba on Strength on Analyst Downgrade
Rigel Pharmaceuticals  – Research Analysts’ Recent Ratings Updates
Rigel Pharmaceuticals – Research Analysts’ Recent Ratings Updates
Zacks: Brokerages Anticipate Oshkosh Co.  Will Post Earnings of $1.47 Per Share
Zacks: Brokerages Anticipate Oshkosh Co. Will Post Earnings of $1.47 Per Share


Leave a Reply

 
© 2006-2018 Zolmax.